Results from our research with 460 real people
Four hard questions every UK mental health operator should ask themselves
Revenue growth, profitability and cashflow... and yet the worst valuation in mental health
a pharma market with a twist
Neurotech, Gen-AI, metabolic psychiatry and more...
How to understand market fundamentals to design better strategy in mental health
+ funding for novel target validation for mental health drug discovery
The bull case, bear case and my verdict on this deal
plus two other interesting studies you should know about
Talkspace, Lifestance, Teladoc and Acadia + what to expect in 2025
plus the impact of the new US administration
Founder Conversations with Isar Mazer of Tacklit
